The global Cold, Cough, and Sore Throat Remedies Market, which was estimated at USD 7.12 billion in 2022, is poised for significant growth, with forecasts indicating a rise to USD 10.4 billion by 2030. This growth is expected to occur at a steady compound annual growth rate (CAGR) of 4.4% during the forecast period spanning from 2023 to 2030.Cold, cough, and sore throat are common respiratory ailments that affect individuals of all ages worldwide. These conditions can be caused by viral infections, bacterial infections, allergies, or environmental factors, leading to symptoms such as congestion, coughing, sneezing, and throat discomfort.
Get Sample PDF @ https://www.snsinsider.com/sample-request/3293
Key Players
The Major Key players are, Reckitt Benckiser, Group PLC, Johnson & Johnson Services, Inc., GlaxoSmithKline plc, Novartis AG, Bayer AG, AstraZeneca ple., Sun Pharmaceutical Industries Ltd., Pfizer Inc., Prestige Brands Holdings, Inc., and Procter & Gamble Co., and others.
Key factors driving the growth of the Cold, Cough, and Sore Throat Remedies Market include:
-
Increasing Incidence of Respiratory Infections: The rising prevalence of respiratory infections, particularly during seasonal outbreaks such as flu season and cold weather months, is driving the demand for over-the-counter (OTC) remedies to alleviate symptoms and promote recovery.
-
Growing Awareness and Self-Care Practices: Increasing awareness among consumers about the importance of early symptom management and self-care practices for cold, cough, and sore throat is driving the demand for a variety of remedies, including cough syrups, lozenges, decongestants, and throat sprays.
-
Innovation in Product Formulations: Ongoing innovation in product formulations, including the development of multi-symptom relief formulations, natural and herbal remedies, and convenient dosage forms such as chewable tablets and liquid gels, is expanding the options available to consumers for managing respiratory symptoms.
-
Evolving Consumer Preferences: Changing consumer preferences towards non-prescription remedies, convenience-driven healthcare solutions, and natural or herbal alternatives are shaping the landscape of the Cold, Cough, and Sore Throat Remedies Market, driving market growth.
KEY SEGMENTS
By Drug
-
Antihistamines
-
Expectorants
-
Bronchodilators
-
Decongestants
-
Antibiotics
-
Others
By Doses
-
Oral Syrups
-
Tablets/Pills
-
Nasal Drops
-
Lozenges
-
Others
By Distribution Channel
-
Hospital Pharmacies
-
Retail Pharmacies
-
Drug Stores
-
Supermarkets/Hypermarkets
-
E-Commerce/Online Pharmacies
The forecast period of 2023-2030 is expected to witness continued product innovation, marketing initiatives, and strategic collaborations among key players to capitalize on emerging trends and meet evolving consumer needs in the global market for cold, cough, and sore throat remedies.
Geographically, North America currently dominates the Cold, Cough, and Sore Throat Remedies Market, attributed to high healthcare expenditure, widespread availability of OTC remedies, and seasonal fluctuations in respiratory infections. However, regions such as Europe, Asia Pacific, and Latin America are anticipated to witness significant growth opportunities during the forecast period, driven by increasing consumer awareness and expanding retail distribution channels.
About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
Contact Us:
Akash Anand – Head of Business Development & Strategy
Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)
Website: https://www.snsinsider.com